Cinacalcet does not affect longitudinal growth but increases body weight gain in experimental uraemia

Nephrology Dialysis Transplantation

Volumn 23, Issue 9, 2008, Pages 2761-2767

  Nakagawa, Kumiko ^a   Pérez, Eduardo C ^b   Oh, Jun ^a   Santos, Fernando ^b   Geldyyev, Aman ^a   Gross, Marie L ^a   Schaefer, Franz ^a   Schmitt, Claus P ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c Center for Pediatrics and Adolescent Medicine   (Germany)

Author keywords

Calcimimetic agents; Calcium receptor; Growth plate chondrocyte; Longitudinal growth; Rats

Indexed keywords

BROXURIDINE; CALCEIN; CALCIUM; CINACALCET; PARATHYROID HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY GROWTH; CALCIUM BLOOD LEVEL; CARTILAGE CELL; CELL PROLIFERATION; CONTROLLED STUDY; FOOD INTAKE; GROWTH PLATE; MALE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; TIBIA; TREATMENT RESPONSE; UREMIA; WEIGHT GAIN;

ANIMALS; BIOMETRY; CELL PROLIFERATION; CHONDROCYTES; GROWTH PLATE; IMMUNOHISTOCHEMISTRY; MALE; NAPHTHALENES; RATS; RATS, SPRAGUE-DAWLEY; UREMIA; WEIGHT GAIN;

EID: 51549088011     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn143     Document Type: Article

References (41)

1. Strippoli GF, Tong A, Palmer SC et al. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Database Syst Rev 2006; 18: CD006254
2. Cunningham J, Danese M, Olson K et al. Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int 2005; 68: 1793-1800
3. Mehls O, Ritz E, Kreusser W et al. Renal osteodystrophy in uraemic children. Clin Endocrinol Metab 1980; 9: 151-176
4. Groothoff JW, Offringa M, Van Eck-Smit BL et al. Severe bone disease and low bone mineral density after juvenile renal failure. Kidney Int 2003; 63: 266-275
5. Oh J, Wunsch R, Turzer M et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002; 106: 100-105
6. Block GA, Hulbert-Shearon TE, Levin NW et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607-617
7. Van Der Eerden BC, Karperien M, Wit JM. Systemic and local regulation of the growth plate. Endocr Rev 2003; 24: 782-801
8. Nilsson O, Marino R, De Luca F et al. Endocrine regulation of the growth plate. Horm Res 2005; 64: 157-165
9. Bonen DK, Schmid TM. Elevated extracellular calcium concentrations induce type X collagen synthesis in chondrocyte cultures. J Cell Biol 1991; 115: 1171-1178
10. Mancilla EE, Galindo M, Fertilio B et al. L-type calcium channels in growth plate chondrocytes participate in endochondral ossification. J Cell Biochem 2007; 101: 389-398
11. Chang W, Tu C, Chen TH et al. Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology 1999; 140: 5883-5893
12. 2+ sensing receptor activation in the growth plate. FASEB J 2004; 18: 143-145
13. Oz OK, Zerwekh JE, Fisher C et al. Bone has a sexually dimorphic response to aromatase deficiency. J Bone Miner Res 2000; 15: 507-514
14. Van Der Eerden BC, van Til NP, Brinkmann AO et al. Gender differences in expression of androgen receptor in tibial growth plate and metaphyseal bone of the rat. Bone 2002; 30: 891-896
15. Amil B, Fernandez-Fuente M, Molinos I et al. Chondromodulin-I expression in the growth plate of young uremic rats. Kidney Int 2004; 66: 51-59
16. Erben RG. Embedding of bone samples in methylmethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry. J Histochem Cytochem 1997; 45: 307-313
17. Zuscik MJ, D'Souza M, Ionescu AM et al. Growth plate chondrocyte maturation is regulated by basal intracellular calcium. Exp Cell Res 2002; 276: 310-319
18. Iannotti JP, Brighton CT. Cytosolic ionized calcium concentration in isolated chondrocytes from each zone of the growth plate. J Orthop Res 1989; 7: 511-518
19. Kirsch T, Swoboda B, von der Mark K. Ascorbate independent differentiation of human chondrocytes in vitro: simultaneous expression of types I and X collagen and matrix mineralization. Differentiation 1992; 52: 89-100
20. + receptor-stimulated hormone release from sheep thyroid parafollicular cells. J Physiol 1997; 502: 31-44
21. Fox J, Lowe SH, Petty BA et al. NPS R-568: a type II calcimimetic compound that acts on parathyroid cell calcium receptor of rats to reduce plasma levels of parathyroid hormone and calcium. J Pharmacol Exp Ther 1999; 290: 473-479
22. Nemeth EF, Heaton WH, Miller M et al. Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. J Pharmacol Exp Ther 2004; 308: 627-635
23. Rodriguez L, Cheng Z, Chen TH et al. Extracellular calcium and parathyroid hormone-related peptide signaling modulate the pace of growth plate chondrocyte differentiation. Endocrinology 2005; 146: 4597-4608
24. Lee K, Lanske B, Karaplis AC et al. Parathyroid hormone-related peptide delays terminal differentiation of chondrocytes during endochondral bone development. Endocrinology 1996; 137: 5109-5118
25. Lanske B, Karaplis AC, Lee K et al. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 1996; 273: 663-666
26. Garner SC, Pi M, Tu Q et al. Rickets in cation-sensing receptor-deficient mice: an unexpected skeletal phenotype. Endocrinology 2001; 142: 3996-4005
27. Kos CH, Karaplis AC, Peng JB et al. The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone. J Clin Invest 2003; 111: 1021-1028
28. Tu Q, Pi M, Karsenty G et al. Rescue of the skeletal phenotype in CasR-deficient mice by transfer onto the Gcm2 null background. J Clin Invest 2003; 111: 1029-1037
29. Mittelman SD, Hendy GN, Fefferman RA et al. A hypocalcemic child with a novel activating mutation of the calcium-sensing receptor gene: successful treatment with recombinant human parathyroid hormone. J Clin Endocrinol Metab 2006; 91: 2474-2479
30. Burren CP, Curley A, Christie P et al. A family with autosomal dominant hypocalcaemia with hypercalciuria (ADHH): mutational analysis, phenotypic variability and treatment challenges. J Pediatr Endocrinol Metab 2005; 18: 689-699
31. Uckun-Kitapci A, Underwood LE, Zhang J et al. A novel mutation (E767K) in the second extracellular loop of the calcium sensing receptor in a family with autosomal dominant hypocalcemia. Am J Med Genet A 2005; 132: 125-129
32. Mehls O, Ritz E, Hunziker EB et al. Improvement of growth and food utilization by human recombinant growth hormone in uremia. Kidney Int 1988; 33: 45-52
33. Kovacs GT, Oh J, Kovacs J et al. Growth promoting effects of growth hormone and IGF-I are additive in experimental uremia. Kidney Int 1996; 49: 1413-1421
34. Schmitt CP, Hessing S, Oh J et al. Intermittent administration of parathyroid hormone (1-37) improves growth and bone mineral density in uremic rats. Kidney Int 2000; 57: 1484-1492
35. Fernandez-Fuente M, Santos F, Carbajo-Perez E et al. Growth plate height of uremic rats is influenced by severity and duration of renal failure. Pediatr Nephrol 2004; 19: 187-192
36. Sanchez CP, Salusky IB, Kuizon BD et al. Growth of long bones in renal failure: roles of hyperparathyroidism, growth hormone and calcitriol. Kidney Int 1998; 54: 1879-1887
37. Henley C, Colloton M, Cattley RC et al. 1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism. Nephrol Dial Transplant 2005; 20: 1370-1377
38. Nemeth EF, Heaton WH, Miller M et al. Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. J Pharmacol Exp Ther 2004; 308: 627-3539
39. Mitch WE. Proteolytic mechanisms, not malnutrition, cause loss of muscle mass in kidney failure. J Ren Nutr 2006; 16: 208-211
40. Sun DF, Chen Y, Rabkin R.Work-induced changes in skeletal muscle IGF-1 and myostatin gene expression in uremia. Kidney Int 2006; 70: 453-459
41. Mak RH, Cheung W. Cachexia in chronic kidney disease: role of inflammation and neuropeptide signaling. Curr Opin Nephrol Hypertens 2007; 16: 27-31